via MedicalXpress
A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Researchers from the University of Helsinki have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson’s, as well as protecting the dopamine-producing brain cells from dying.
The results from the study, co-funded by Parkinson’s UK, showed an increase in dopamine levels in the brains of mice following treatment with the molecule. BT13 also activated a specific receptor in the mouse brains to protect the cells.
These findings suggest that BT13 could have the potential to lead to a new drug treatment that can slow, stop or even reverse the loss of brain cells in Parkinson’s.
Why is dopamine important?
Typically, by the time people are diagnosed with Parkinson’s, they have already lost 70-80 per cent of their dopamine-producing cells. These are involved in coordinating movement.
Current treatments mask the symptoms, but there is nothing that can slow down its progression or prevent more brain cells from being lost. As dopamine levels continue to fall, symptoms get worse and new symptoms can appear.
The role of BT13
Researchers are now working on improving the properties of BT13 to make it more effective as a potential treatment. If successful, this could benefit the 145,000 people living with Parkinson’s in the UK.
The study builds on previous research on another molecule that targets the same receptors in the brain, glial cell line-derived neurotrophic factor (GDNF), an experimental treatment for Parkinson’s which was the subject of a major clinical trial funded by Parkinson’s UK. While the results were not clear cut, GDNF has shown promise to restore damaged cells in Parkinson’s.
The GDNF protein requires complex surgery to deliver the treatment to the brain because it’s a large molecule. However BT13, a smaller molecule, could be more easily administered as a treatment if shown to be beneficial in further clinical trials.
“The molecule holds great promise”
Professor David Dexter, Deputy Director of Research at Parkinson’s UK, said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms.
“One of the biggest challenges for Parkinson’s research is how to get drugs past the blood-brain barrier, so the exciting discovery of BT13 has opened up a new avenue for research to explore.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Parkinson’s
- Parkinson's support group holding Christmas dinner, silent auction
A Christmas event to support families with Parkinson’s disease is coming to the My People Senior Activity Center on Thursday, Dec. 14.
- Parkinson's Disease: 'You can have a career after diagnosis'
While reading the BBC website, I came across an article on Dr Paul Sinha, from the TV programme, The Chase. He had been diagnosed with Parkinson's. There was a link to his blog which explained his ...
- Award success for 1FitLife’s work to support people living with Parkinson’s disease
1FitLife was Highly Commended at The Parkinson’s Excellence Network Awards Health and wellness content creator, 1FitLife, was awarded ‘Highly Commended’ at the Parkinson’s UK Excellence Network Awards ...
- MUSC named new study site for Parkinson’s based research
The Medical University of South Carolina (MUSC) has been designated as a research study site for the Black and African American Connections to Parkinson’s Disease (BLAAC PD), said the organization.
- Blood test spots Parkinson's risk before symptoms
Researchers in Oxford have developed a blood test to identify people likely to develop Parkinson's disease. The Nuffield Department of Clinical Neurosciences at Oxford University said the test could ...
Go deeper with Google Headlines on:
Parkinson’s
[google_news title=”” keyword=”Parkinson’s” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
BT13
- What is the average salary for Bookkeeper jobs?
*Job counts are based on last month's totals. To see the latest jobs we have right now within a location in the UK, just perform a job search from the homepage or try our browse jobs pages. You can ...
- The Best Starter Decks In The Digimon TCG
The Giga Green deck suspends opponents' Digimon and deals damage using the Piercing effect, and the Heaven's Yellow deck stalls opponents with the Recover mechanic.
- D-BT13 Flight of Chakrabarthi Sneak Peek GG Central
Time Fri Dec 01 2023 at 03:00 pm to 07:00 pm (GMT+11:00) ...
- Digimon Card Game: Versus Royal Knights – Booster Box (BT13)
The shop has an amazing catalogue at very advantageous prices. The delivery is very quick and customer service very professional and nice. The shop has an amazing catalogue at very advantageous prices ...
- Golden Star Battery Tray 1955-1956 Chevy 150/210/Bel Air
Direct replacement for Navistar 2029260C2. Battery Trays. 1978-88 GM G-Body Cars Include -1982-1987 Buick Regal 1978-1983 Chevy Malibu 1982-1988 Chevy Monte Carlo 1982-1987 Chevy El Camino and GMC ...
Go deeper with Google Headlines on:
BT13
[google_news title=”” keyword=”BT13″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]